• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amwell Expands Leadership Team with Appointment of Dr. Carrie Nelson as Chief Medical Officer

    6/8/22 8:30:00 AM ET
    $AMWL
    Business Services
    Consumer Discretionary
    Get the next $AMWL alert in real time by email

    Innovative physician leader brings more than two decades experience to Amwell clinical, go to market and customer success initiatives

    Amwell® (NYSE:AMWL), a digital care delivery leader, has named Dr. Carrie Nelson as its new Chief Medical Officer. In this role, Dr. Nelson will focus on empowering provider and payer organizations as they seek to achieve greater clinical, operational, and financial outcomes through digital care delivery powered by Converge™, Amwell's enterprise-grade infrastructure software platform. Dr. Nelson will also be responsible for leading clients in their improvement of population health in today's new era of hybrid healthcare and will have clinical oversight of healthcare professionals practicing on behalf of Amwell clinical partner, the Amwell Medical Group.

    "We are honored to welcome Carrie to our executive team. Her experience as a physician and her impressive background in value-based care and focus on driving health outcomes and risk management for large provider organizations, make her the right person to extend our clinical vision," said Kurt Knight, Chief Operating Officer, Amwell. "Carrie's clinical perspective will be crucial to the continued sales and implementation of our infrastructure software, which provides the engine to connect and empower healthcare organizations as they pursue their digital care delivery aspirations. Carrie will help our customers define new standards of care, drive important quality metrics, and achieve efficiencies, while enhancing patient and provider experiences across the care continuum."

    Dr. Nelson joins Amwell from Advocate Aurora Health where she most recently served as Senior Vice President and CMO for Population Health and Health Outcomes. She also served as the Chief Clinical Officer for Advocate Physician Partners, a benchmark organization known internationally for delivering value-based care in collaboration with about 5000 employed and independent physician practices. With more than 28 years' experience as a Family Medicine provider, Dr. Nelson is an innovative physician leader with a proven track record in the fields of quality improvement, patient safety and population health. Having served on the board and as president of the Illinois Academy of Family Physicians, she has been a leader at the national level, has chaired the American Academy of Family Physicians Commission on Science and Health of the Public, and has regularly engaged in influencing healthcare policy.

    "As a physician, I am passionate about improving patient care and have a deep understanding of the unique challenges that care teams face every day. These challenges have only worsened following the pandemic, and I believe that technology has the power to improve outcomes and address the retention and burnout crisis currently facing our healthcare system," said Dr. Nelson. "I am excited to have the opportunity to help deliver on Amwell's vision for empowering digital care delivery, as we work to enable an integrated experience across a full spectrum of physical, virtual and automated care – and make it easier for healthcare organizations to achieve their digital care delivery goals."

    About Amwell

    Amwell is a leading digital care delivery platform in the United States and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that digital care delivery will transform healthcare. The Company offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With over a decade of experience, Amwell powers digital health solutions for over 2,000 hospitals and 55 health plan partners with over 36,000 employers, covering over 80 million lives. For more information, please visit https://business.amwell.com/.

    American Well, Amwell, SilverCloud, Conversa, Converge and Carepoint are registered trademarks or trademarks of American Well Corporation in the United States and other countries. All other trademarks used herein are the property of their respective owners.

    Forward-Looking Statements

    This press release contains forward-looking statements about us and our industry that involve substantial risks and uncertainties and are based on our beliefs and assumptions and on information currently available to us. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations, financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "will," or "would," or the negative of these words or other similar terms or expressions.

    Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements represent our beliefs and assumptions only as of the date of this release. These statements, and related risks, uncertainties, factors and assumptions, include, but are not limited to: weak growth and increased volatility in the telehealth market; inability to adapt to rapid technological changes; increased competition from existing and potential new participants in the healthcare industry; changes in healthcare laws, regulations or trends and our ability to operate in the heavily regulated healthcare industry; our ability to comply with federal and state privacy regulations; the significant liability that could result from a cybersecurity breach; and other factors described under ‘Risk Factors' in our most recent form 10-K filed with the SEC. These risks are not exhaustive. Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. Further information on factors that could cause actual results to differ materially from the results anticipated by our forward-looking statements is included in the reports we have filed or will file with the Securities and Exchange Commission. These filings, when available, are available on the investor relations section of our website at investors.amwell.com and on the SEC's website at www.sec.gov.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20220608005153/en/

    Get the next $AMWL alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $AMWL

    DatePrice TargetRatingAnalyst
    1/13/2025$15.00Equal Weight → Overweight
    Wells Fargo
    8/3/2023$5.00 → $2.50Overweight → Equal-Weight
    Morgan Stanley
    3/23/2023$5.00 → $2.50Outperform → Market Perform
    TD Cowen
    2/27/2023$5.00 → $3.50Overweight → Neutral
    Piper Sandler
    1/4/2023$4.20Neutral → Buy
    BofA Securities
    9/7/2022$5.00Hold
    Truist
    4/14/2022$6.00Buy
    Guggenheim
    4/1/2022$5.00Neutral
    Credit Suisse
    More analyst ratings

    $AMWL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President, International Gotlib Phyllis sold $42,773 worth of shares (4,958 units at $8.63), decreasing direct ownership by 3% to 136,891 units (SEC Form 4)

      4 - American Well Corp (0001393584) (Issuer)

      7/1/25 4:35:20 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Chief Accounting Officer Mcneice Paul Francis sold $2,856 worth of shares (331 units at $8.63), decreasing direct ownership by 2% to 14,005 units (SEC Form 4)

      4 - American Well Corp (0001393584) (Issuer)

      7/1/25 4:34:31 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Director Jackson Deborah C was granted 20,891 shares, increasing direct ownership by 66% to 52,725 units (SEC Form 4)

      4 - American Well Corp (0001393584) (Issuer)

      6/16/25 4:31:47 PM ET
      $AMWL
      Business Services
      Consumer Discretionary

    $AMWL
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Amwell makes grant to new employee under inducement plan

      BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading technology-enabled care platform provider, announced that on May 6, Amwell made a grant of RSUs of 3,451 shares of its Class A common stock to one new employee. The grant was offered as material inducement to the employee's employment with Amwell. The RSUs will vest as follows, subject to the employee's continued employment through the applicable vesting date: 25% of the RSUs will vest upon the first anniversary of the grant date ("Initial Vesting Date"), and the remaining 75% of the RSUs will vest in equal pro rata increments every three months thereafter (beginning on the first calendar day of the month following the

      5/6/25 4:05:00 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell® Announces Results for First Quarter 2025

      BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter ended March 31. Visit Amwell's investor relations website at investors.amwell.com to view the first quarter 2025 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, May 1. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/9tn5fcf6. A replay of the call will be available via webcast shortly after the completion of the call, at investors.amwell.com. About Amwell Amwell offers payers and

      5/1/25 4:05:00 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell® to participate in upcoming investor conferences

      BOSTON, April 24, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will participate in the following upcoming investor conferences:   On May 8, Mark Hirschhorn, chief financial officer and chief operating officer, will participate in one-on-one meetings at the Needham & Co. Virtual Technology and Services Conference held virtually. On June 24, Hirschhorn will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference in New York City.    About Amwell Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technolo

      4/24/25 7:30:00 AM ET
      $AMWL
      Business Services
      Consumer Discretionary

    $AMWL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $AMWL
    SEC Filings

    See more
    • Amwell upgraded by Wells Fargo with a new price target

      Wells Fargo upgraded Amwell from Equal Weight to Overweight and set a new price target of $15.00

      1/13/25 7:29:38 AM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded Amwell from Overweight to Equal-Weight and set a new price target of $2.50 from $5.00 previously

      8/3/23 6:19:10 AM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell downgraded by TD Cowen with a new price target

      TD Cowen downgraded Amwell from Outperform to Market Perform and set a new price target of $2.50 from $5.00 previously

      3/23/23 7:15:52 AM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • American Well Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - American Well Corp (0001393584) (Filer)

      6/17/25 4:57:19 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amendment: SEC Form SCHEDULE 13G/A filed by American Well Corporation

      SCHEDULE 13G/A - American Well Corp (0001393584) (Subject)

      5/15/25 4:21:34 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • SEC Form 10-Q filed by American Well Corporation

      10-Q - American Well Corp (0001393584) (Filer)

      5/1/25 4:13:22 PM ET
      $AMWL
      Business Services
      Consumer Discretionary

    $AMWL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by American Well Corporation

      SC 13G/A - American Well Corp (0001393584) (Subject)

      11/12/24 4:43:25 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • SEC Form SC 13G filed by American Well Corporation

      SC 13G - American Well Corp (0001393584) (Subject)

      11/6/24 4:14:27 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • SEC Form SC 13G filed by American Well Corporation

      SC 13G - American Well Corp (0001393584) (Subject)

      11/4/24 11:53:44 AM ET
      $AMWL
      Business Services
      Consumer Discretionary

    $AMWL
    Financials

    Live finance-specific insights

    See more
    • Amwell® Announces Results for First Quarter 2025

      BOSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL) a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the first quarter ended March 31. Visit Amwell's investor relations website at investors.amwell.com to view the first quarter 2025 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, May 1. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/9tn5fcf6. A replay of the call will be available via webcast shortly after the completion of the call, at investors.amwell.com. About Amwell Amwell offers payers and

      5/1/25 4:05:00 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell® to report first quarter 2025 operating results

      BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leader in digital care, will report first quarter 2025 operating results after stock market trading hours on Thursday, May 1 2025. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The full earnings report and the live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell.com for approximately 90 days. About Amwell  Amwell offers payers and

      4/17/25 7:05:00 AM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell® Announces Results for Fourth Quarter and Full Year 2024

      BOSTON, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the fourth quarter and full year ended Dec. 31, 2024. Visit Amwell's investor relations website at investors.amwell.com to view the fourth quarter and full year 2024 earnings report. The company will host a conference call to discuss its financial results today at 5 p.m. ET, Feb. 12. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/zsp4abpw. A replay of the call will be available via webcast shortly after the completion of the call, at investors.amwell.com. Abo

      2/12/25 4:05:00 PM ET
      $AMWL
      Business Services
      Consumer Discretionary

    $AMWL
    Leadership Updates

    Live Leadership Updates

    See more
    • Amwell announces new chief financial officer

      BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leader in digital care, today announced Mark Hirschhorn will become Amwell Chief Financial Officer (CFO) effective Oct. 21, succeeding Robert "Bob" Shepardson, who has been in the role since 2021. Hirschhorn will oversee Amwell's financial operations, enterprisewide optimization and capital allocation activities, and will play a meaningful leadership role in guiding the company's strategy to support its long-term growth objectives and enhance shareholder value.   Hirschhorn is a healthcare technology industry leader, with over three decades of experience in financial and strategic operations, having served in senior executiv

      10/15/24 4:30:00 PM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Amwell Announces Appointment of Ricky Goldwasser to its Board of Directors

      Boston, June 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE:AMWL), a leader in hybrid care enablement, today announces the appointment of Ricky Goldwasser to the company's Board of Directors, effective June 13. "Ricky brings to our board a deep financial background that makes her an invaluable addition as we focus on Amwell's path to profitability. Ricky's strong voice coupled with her impressive track record will help guide Amwell as we strive for greater efficiencies, optimized cash flow and profitable growth, while remaining committed to enabling our clients to achieve their goals. We are pleased to welcome Ricky to the team," said Ido Schoenberg, M.D., CEO and chairman, Amwell. Ms. Gol

      6/17/24 8:05:00 AM ET
      $AMWL
      Business Services
      Consumer Discretionary
    • Axogen, Inc. Appoints Kathy Weiler to its Board of Directors

      ALACHUA, Fla. and TAMPA, Fla., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, is pleased to announce today the appointment of Mrs. Kathy Weiler to its Board of Directors, effective December 20, 2023. Weiler, a senior executive with 20+ years of experience and proven track record in driving strategic commercial initiatives, will serve on the Board's Governance, Nominating and Sustainability Committee, and the Quality, Compliance, and Portfolio Management Committee. "I am happy to welcome Kathy to the Board as Axogen is approaching an exciting inflection point in its journ

      12/26/23 4:15:00 PM ET
      $AMWL
      $AXGN
      Business Services
      Consumer Discretionary
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care